The two companies announced a strategic collaboration to build the Fortinet Security Processor 6, the custom silicon inside its FortiGate firewalls. Intel will handle the chip design, advanced packaging, and manufacturing. The first name on the list Th…
Look at what Alphabet, Microsoft, Amazon, Meta, and Oracle officially owe, and the numbers seem large but manageable. Look off the books, and a second, bigger pile of debt appears. A Nikkei study put that hidden figure at $1.65 trillion, up roughly eig…
Google’s answer to a summer of being outrun is not a bigger model. It is cheaper ones. On Tuesday the company launched three new Gemini models, all at its fast, low-cost “Flash” tier, a day before Alphabet reports earnings. The message is efficiency ov…
The other two major labels made peace with Udio months ago. Sony did the opposite. On Monday it filed a fresh lawsuit in New York, Billboard reported, covering 30,117 recordings and leaving Udio facing a far bigger bill. Turning peace into a weapon The…
Reviews are in for The Hawk, Will Ferrell’s new Netflix comedy series, and we can see how it compares to his long history of movies.
Nvidia’s Vera Rubin platform combines CPUs and GPUs into a single system, reflecting the company’s growing ambition to power every layer of AI infrastructure.
When founders talk about growth, the conversation usually centers on product development, hiring, revenue, customer acquisition, or fundraising. Those factors matter. They are the engines that move a company forward. Yet after years of working with hig…
The next big customer for a payments company may not be a person at all. It may be an AI agent, and a startup called Natural has raised $30 million to serve it. The Series A was led by Kirsten Green at Forerunner Ventures, and closed when Natural was j…
Most security teams face the same problem. There are far more flaws than anyone can fix, and no clear way to know which ones matter. Empirical Security wants to predict the answer. The Chicago startup’s Series A was led by Brightmind Partners, chief ex…
The FDA could decide whether to loosen rules around peptide production this week. Some telehealth players are already seeing dollar signs.